معرفی
Mette Moe serves as a Senior Physician (Overlæge) at Aalborg University Hospital within the Faculty of Medicine's Department of Oncology. Her research focuses on genitourinary cancers with particular expertise in prostate and bladder cancer treatment modalities.
Her primary research interests include:
- Prostate cancer therapeutics and outcomes
- Patient-reported outcome measures in oncology
- Radiation therapy safety and efficacy
- Chemotherapy regimens for urothelial cancers
- Molecular imaging applications in cancer management
Analysis of her recent publications reveals a strong focus on precision oncology approaches, particularly PSMA-targeted radioligand therapy for prostate cancer as demonstrated in the VISION trial publications. Her work consistently integrates both physician-assessed and patient-reported outcomes, reflecting a patient-centered research approach. The publications span clinical trials methodology, safety analyses, and comparative treatment efficacy studies with emphasis on real-world applications.
Moe actively collaborates with multidisciplinary research teams across Denmark and internationally, as evidenced by her co-authorship on major clinical trials. Her work has generated significant academic attention with multiple publications garnering substantial citations and media coverage, including an upcoming media event in August 2025 regarding real-world data on PSMA PET/CT imaging prior to salvage radiotherapy.
She contributes to both clinical practice and research within the Department of Oncology, with particular involvement in studies examining treatment-related morbidity and quality of life outcomes for cancer patients undergoing radiation and systemic therapies.
